John Nkengasong
#50,315
Most Influential Person Now
Cameroonian virologist
John Nkengasong's AcademicInfluence.com Rankings
John Nkengasongbiology Degrees
Biology
#4905
World Rank
#7253
Historical Rank
Virology
#125
World Rank
#129
Historical Rank
Microbiology
#898
World Rank
#987
Historical Rank
Download Badge
Biology
John Nkengasong's Degrees
- Bachelors Microbiology University of Yaoundé
- Masters Virology University of Yaoundé
- PhD Virology University of Yaoundé
Why Is John Nkengasong Influential?
(Suggest an Edit or Addition)According to Wikipedia, John N. Nkengasong is a Cameroonian-American virologist serving as the Global AIDS Coordinator in the Biden administration since 2022 and Senior Bureau Official for Global Health Security and Diplomacy since 2023. He previously worked as the Director of the Africa Centres for Disease Control and Prevention from 2016 to 2022, as well as at the World Health Organization and Centers for Disease Control and Prevention. During the COVID-19 pandemic, Nkengasong was appointed the WHO Special Envoy for Africa.
John Nkengasong's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial (1999) (594)
- Laboratory Diagnosis of Tuberculosis in Resource-Poor Countries: Challenges and Opportunities (2011) (468)
- Looming threat of COVID-19 infection in Africa: act collectively, and fast (2020) (279)
- Serology testing in the COVID-19 pandemic response (2020) (240)
- The puzzle of HIV‐1 subtypes in Africa (1997) (218)
- Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials (2003) (210)
- Detection of Recent HIV-1 Infection Using a New Limiting-Antigen Avidity Assay: Potential for HIV-1 Incidence Estimates and Avidity Maturation Studies (2012) (197)
- Cutting Edge: Resistance to HIV-1 Infection among African Female Sex Workers Is Associated with Inhibitory KIR in the Absence of Their HLA Ligands1 (2006) (189)
- A new twenty-first century science for effective epidemic response (2019) (185)
- The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study (2021) (181)
- The World Health Organization African region laboratory accreditation process: improving the quality of laboratory systems in the African region. (2010) (171)
- Genotypic subtypes of HIV‐1 in Cameroon (1994) (164)
- COVID-19 in Africa: the spread and response (2020) (164)
- Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte d'Ivoire (2003) (156)
- Hepatitis C virus genotyping by means of 5'-UR/core line probe assays and molecular analysis of untypeable samples. (1995) (154)
- Breast-feeding and Transmission of HIV-1. (2004) (150)
- Protease sequences from HIV-1 group M subtypes A–H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide (2000) (149)
- Laboratory Systems and Services Are Critical in Global Health (2010) (142)
- Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women. (2001) (111)
- Scale-up of HIV Viral Load Monitoring--Seven Sub-Saharan African Countries. (2015) (110)
- Strengthening public health surveillance and response using the health systems strengthening agenda in developing countries (2010) (109)
- Improving quality management systems of laboratories in developing countries: an innovative training approach to accelerate laboratory accreditation. (2010) (108)
- Laboratory challenges in the scaling up of HIV, TB, and malaria programs: The interaction of health and laboratory systems, clinical research, and service delivery. (2009) (106)
- Infant human immunodeficiency virus diagnosis in resource-limited settings: issues, technologies, and country experiences. (2007) (106)
- Genetic and phylogenetic analysis of env subtypes G and H in central Africa. (1994) (106)
- Optimization of a Low Cost and Broadly Sensitive Genotyping Assay for HIV-1 Drug Resistance Surveillance and Monitoring in Resource-Limited Settings (2011) (106)
- HIV-1 Drug Resistance Emergence among Breastfeeding Infants Born to HIV-Infected Mothers during a Single-Arm Trial of Triple-Antiretroviral Prophylaxis for Prevention of Mother-To-Child Transmission: A Secondary Analysis (2011) (106)
- Multivariate analysis of human immunodeficiency virus type 1 neutralization data (1996) (103)
- Progress with Scale-Up of HIV Viral Load Monitoring - Seven Sub-Saharan African Countries, January 2015-June 2016. (2016) (102)
- Longstanding presence in Belgians of multiple non-B HIV-1 subtypes (1996) (101)
- Sensitivity and Specificity of Human Immunodeficiency Virus Rapid Serologic Assays and Testing Algorithms in an Antenatal Clinic in Abidjan, Ivory Coast (2001) (100)
- Development of two avidity-based assays to detect recent HIV type 1 seroconversion using a multisubtype gp41 recombinant protein. (2010) (98)
- China’s response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response (2020) (98)
- Antiretroviral therapy in HIV‐2‐infected patients: changes in plasma viral load, CD4+ cell counts, and drug resistance profiles of patients treated in Abidjan, Côte d'Ivoire (2003) (95)
- Critical role of developing national strategic plans as a guide to strengthen laboratory health systems in resource-poor settings. (2009) (93)
- Population-Based Biochemistry, Immunologic and Hematological Reference Values for Adolescents and Young Adults in a Rural Population in Western Kenya (2011) (90)
- A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa. (2008) (85)
- The puzzle of the COVID-19 pandemic in Africa (2020) (84)
- Let Africa into the market for COVID-19 diagnostics (2020) (84)
- Integrating Prevention of Mother-to-Child HIV Transmission Into Routine Antenatal Care: The Key to Program Expansion in Cameroon (2005) (83)
- Detection of Phylogenetically Diverse Human Immunodeficiency Virus Type 1 Groups M and O from Plasma by Using Highly Sensitive and Specific Generic Primers (1999) (82)
- Recalibration of the Limiting Antigen Avidity EIA to Determine Mean Duration of Recent Infection in Divergent HIV-1 Subtypes (2015) (81)
- Importance of diagnostics in epidemic and pandemic preparedness (2019) (78)
- Scaling up HIV rapid testing in developing countries: comprehensive approach for implementing quality assurance. (2010) (77)
- Role of the Laboratory in Ensuring Global Access to ARV Treatment for HIV-Infected Children: Consensus Statement on the Performance of Laboratory Assays for Early Infant Diagnosis (2008) (77)
- The Lancet Commission on diagnostics: transforming access to diagnostics (2021) (75)
- COVID-19: Shining the Light on Africa (2020) (73)
- The SLMTA programme: Transforming the laboratory landscape in developing countries (2014) (72)
- High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Côte d'Ivoire. (2001) (69)
- Predominance of human immunodeficiency virus type 2 subtype B in Abidjan, Ivory Coast. (1999) (68)
- Evaluation of HIV serial and parallel serologic testing algorithms in Abidjan, Côte d'Ivoire. (1999) (65)
- Dried blood spot specimens are a suitable alternative sample type for HIV-1 viral load measurement and drug resistance genotyping in patients receiving first-line antiretroviral therapy. (2012) (63)
- COVID-19 vaccines: how to ensure Africa has access (2020) (63)
- COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead (2021) (61)
- Threshold survey evaluating transmitted HIV drug resistance among public antenatal clinic clients in Addis Ababa, Ethiopia (2007) (59)
- Development and Application of a Broadly Sensitive Dried-Blood-Spot-Based Genotyping Assay for Global Surveillance of HIV-1 Drug Resistance (2010) (59)
- High Prevalence of Genotypic and Phenotypic HIV‐1 Drug‐Resistant Strains Among Patients Receiving Antiretroviral Therapy in Abidjan, Côte d'lvoire (2001) (59)
- Dried tube specimens: a simple and cost-effective method for preparation of HIV proficiency testing panels and quality control materials for use in resource-limited settings. (2010) (58)
- World Health Organization/HIVResNet Drug Resistance Laboratory Strategy (2008) (58)
- Generation of a consensus sequence from prevalent and incident HIV-1 infections in West Africa to guide AIDS vaccine development. (2002) (58)
- HIV antiretroviral drug resistance in Africa. (2004) (56)
- Genetic analysis of human immunodeficiency virus in Abidjan, Ivory Coast reveals predominance of HIV type 1 subtype A and introduction of subtype G. (1999) (56)
- Presence of diverse human immunodeficiency virus type 1 viral variants in Cameroon. (2000) (56)
- Lack of protection against HIV-1 infection among women with HIV-2 infection. (1999) (55)
- Lower HIV-2 plasma viral loads may explain differences between the natural histories of HIV-1 and HIV-2 infections. (2000) (55)
- Identification of HIV-1 infected infants and young children using real-time RT PCR and dried blood spots from Uganda and Cameroon. (2007) (54)
- COVID-19 testing in Africa: lessons learnt (2020) (53)
- Antigenic evidence of the presence of the aberrant HIV‐1ANT70 virus in Cameroon and Gabon (1993) (53)
- Changes in plasma HIV-1-RNA viral load and CD4 cell counts, and lack of zidovudine resistance among pregnant women receiving short-course zidovudine (2002) (52)
- Suppressed cellular alloimmune responses in HIV‐exposed seronegative female sex workers (2006) (52)
- Cellular human immunodeficiency virus (HIV)-protective factors: a comparison of HIV-exposed seronegative female sex workers and female blood donors in Abidjan, Côte d'Ivoire. (2003) (50)
- Laboratory medicine in low-income and middle-income countries: progress and challenges (2018) (50)
- Analysis of Genetic Variability within the Immunodominant Epitopes of Envelope gp41 from Human Immunodeficiency Virus Type 1 (HIV-1) Group M and Its Impact on HIV-1 Antibody Detection (2000) (50)
- Human Immunodeficiency Virus Type 1 Group M Protease in Cameroon: Genetic Diversity and Protease Inhibitor Mutational Features (2002) (50)
- HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1 (2004) (50)
- Genomic-informed pathogen surveillance in Africa: opportunities and challenges (2021) (49)
- Dual infection with human immunodeficiency virus type 1 and type 2: impact on HIV type 1 viral load and immune activation markers in HIV-seropositive female sex workers in Abidjan, Ivory Coast. (2000) (47)
- Early antiretroviral therapy initiation: access and equity of viral load testing for HIV treatment monitoring. (2017) (47)
- Poor Performance of the Determine HIV-1/2 Ag/Ab Combo Fourth-Generation Rapid Test for Detection of Acute Infections in a National Household Survey in Swaziland (2014) (47)
- Diagnosis of Human Immunodeficiency Virus Infection (2018) (46)
- Preparedness for emerging epidemic threats: a Lancet Infectious Diseases Commission (2019) (45)
- Comparison of NucliSens and Amplicor Monitor Assays for Quantification of Human Immunodeficiency Virus Type 1 (HIV-1) RNA in Plasma of Persons with HIV-1 Subtype A Infection in Abidjan, Côte d’Ivoire (1998) (44)
- HIV/AIDS treatment and HIV vaccines for Africa (2002) (44)
- HIV-specific T helper responses and frequency of exposure among HIV-exposed seronegative female sex workers in Abidjan, Cote d'Ivoire. (2004) (44)
- A shifting paradigm in strengthening laboratory health systems for global health: acting now, acting collectively, but acting differently. (2010) (43)
- Field Evaluation of a Combination of Monospecific Enzyme-Linked Immunosorbent Assays for Type-Specific Diagnosis of Human Immunodeficiency Virus Type 1 (HIV-1) and HIV-2 Infections in HIV-Seropositive Persons in Abidjan, Ivory Coast (1998) (42)
- Virologic and immunologic response to antiretroviral therapy and predictors of HIV type 1 drug resistance in children receiving treatment in Abidjan, Côte d'Ivoire. (2008) (42)
- Field experience in implementing ISO 15189 in Kisumu, Kenya. (2010) (42)
- Update on HIV-1 acquired and transmitted drug resistance in Africa. (2015) (41)
- Africa Centres for Disease Control and Prevention’s framework for antimicrobial resistance control in Africa (2018) (40)
- HIV-1 Viral Load and Other Risk Factors for Mother-to-Child Transmission of HIV-1 in a Breast-Feeding Population in Cote d'Ivoire (2003) (40)
- CRF06‐cpx: A New Circulating Recombinant Form of HIV‐1 in West Africa Involving Subtypes A, G, K, and J (2002) (40)
- Establishing the Africa Centres for Disease Control and Prevention: responding to Africa's health threats. (2017) (39)
- CRF06-cpx: a new circulating recombinant form of HIV-1 in West Africa involving subtypes A, G, K, and J. (2002) (38)
- Laboratory equipment maintenance: A critical bottleneck for strengthening health systems in sub-Saharan Africa? (2012) (38)
- Interpatient genetic variability of HIV-1 group O. (1999) (37)
- Scale-up of Early Infant HIV Diagnosis and Improving Access to Pediatric HIV Care in Global Plan Countries: Past and Future Perspectives (2017) (37)
- Cervicovaginal anti-HIV antibodies in HIV-seronegative female sex workers in Abidjan, Côte d'Ivoire (2000) (37)
- Understanding COVID-19 in Africa (2021) (36)
- Further evidence of the presence of genetically aberrant HIV-1 strains in Cameroon and Gabon. (1994) (35)
- Improved detection of HIV‐2 proviral DNA in dually seroreactive individuals by PCR (1998) (35)
- Improved Specimen-Referral System and Increased Access to Quality Laboratory Services in Ethiopia: The Role of the Public-Private Partnership. (2016) (34)
- Africa Needs a New Public Health Order to Tackle Infectious Disease Threats (2020) (34)
- Strengthening laboratory services and systems in resource-poor countries. (2009) (34)
- HIV testing in developing countries: What is required? (2011) (33)
- Availability and Use of HIV Monitoring and Early Infant Diagnosis Technologies in WHO Member States in 2011–2013: Analysis of Annual Surveys at the Facility Level (2016) (33)
- Reduced capacity of antibodies from patients infected with human immunodeficiency virus type 1 (HIV-1) group O to neutralize primary isolates of HIV-1 group M viruses. (1995) (33)
- Assessment of CD8+ T cell immune activation markers to monitor response to antiretroviral therapy among HIV‐1 infected patients in Côte d’Ivoire (2005) (32)
- Human immunodeficiency virus Type 1 (HIV-1) plasma virus load and markers of immune activation among HIV-infected female sex workers with sexually transmitted diseases in Abidjan, Côte d'Ivoire. (2001) (32)
- Evaluation of United States-Licensed Human Immunodeficiency Virus Immunoassays for Detection of Group M Viral Variants (2001) (31)
- A meta-analysis of the performance of the PimaTM CD4 for point of care testing (2015) (31)
- Changes in HIV RNA viral load, CD4+ T‐cell counts, and levels of immune activation markers associated with anti‐tuberculosis therapy and cotrimoxazole prophylaxis among HIV‐infected tuberculosis patients in Abidjan, Côte d'Ivoire (2005) (30)
- COVID-19 and indirect health implications in Africa: Impact, mitigation measures, and lessons learned for improved disease control (2021) (30)
- Differences in HIV-2 plasma viral load and immune activation in HIV-1 and HIV-2 dually infected persons and those infected with HIV-2 only in Abidjan, Côte D'Ivoire (2004) (30)
- Ensuring the quality of HIV rapid testing in resource-poor countries using a systematic approach to training. (2010) (29)
- Evaluation of the performance of Abbott m2000 and Roche COBAS Ampliprep/COBAS Taqman assays for HIV-1 viral load determination using dried blood spots and dried plasma spots in Kenya (2017) (29)
- Positive Association between β-Chemokine-Producing T Cells and HIV Type 1 Viral Load in HIV-Infected Subjects in Abidjan, Côte d'Ivoire (2002) (29)
- Diagnosis of HIV-1 group O infection by polymerase chain reaction (1995) (28)
- Early Diagnosis of HIV Infection in Infants - One Caribbean and Six Sub-Saharan African Countries, 2011-2015. (2016) (28)
- Simultaneous Detection of Major Drug Resistance Mutations in the Protease and Reverse Transcriptase Genes for HIV-1 Subtype C by Use of a Multiplex Allele-Specific Assay (2013) (28)
- Lack of correlation between V3‐loop peptide enzyme immunoassay serologic subtyping and genetic sequencing (1998) (28)
- Low CD4+ T Cell Counts among African HIV-1 Infected Subjects with Group B KIR Haplotypes in the Absence of Specific Inhibitory KIR Ligands (2011) (27)
- Evaluation of Quantification of HIV-1 RNA Viral Load in Plasma and Dried Blood Spots by Use of the Semiautomated Cobas Amplicor Assay and the Fully Automated Cobas Ampliprep/TaqMan Assay, Version 2.0, in Kisumu, Kenya (2013) (27)
- Polymorphism in protease and reverse transcriptase and phenotypic drug resistance of HIV-1 recombinant CRF02_AG isolates from patients with no prior use of antiretroviral drugs in Abidjan, Côte d'Ivoire. (2003) (27)
- Strengthening the Tuberculosis Specimen Referral Network in Uganda: The Role of Public-Private Partnerships. (2016) (27)
- The centrality of laboratory services in the HIV treatment and prevention cascade: The need for effective linkages and referrals in resource-limited settings. (2014) (27)
- Re-imagining the future of diagnosis of Neglected Tropical Diseases (2017) (26)
- Specimen origin, type and testing laboratory are linked to longer turnaround times for HIV viral load testing in Malawi (2017) (26)
- Changes in levels of immune activation and reconstitution markers among HIV‐1‐infected Africans receiving antiretroviral therapy (2003) (25)
- Interrogating the union: Anglophone Cameroon poetry in the postcolonial matrix (2012) (25)
- Field Evaluation of a Broadly Sensitive HIV-1 In-House Genotyping Assay for Use with both Plasma and Dried Blood Spot Specimens in a Resource-Limited Country (2012) (25)
- Access and Quality of HIV-Related Point-of-Care Diagnostic Testing in Global Health Programs. (2016) (24)
- Realizing the potential of routine viral load testing in sub‐Saharan Africa (2017) (24)
- Mortality Among HIV-1-Infected Women According to Children's Feeding Modality: An Individual Patient Data Meta-Analysis (2005) (24)
- Antibodies to V3 loop peptides derived from chimpanzee lentiviruses and the divergent HIV‐1ANT‐70 isolate in human sera from different geographic regions (1994) (23)
- Comparison of Ahlstrom Grade 226, Munktell TFN, and Whatman 903 Filter Papers for Dried Blood Spot Specimen Collection and Subsequent HIV-1 Load and Drug Resistance Genotyping Analysis (2012) (23)
- Combatting Global Infectious Diseases: A Network Effect of Specimen Referral Systems (2017) (23)
- Virologic, immunologic, and clinical follow‐up of a couple infected by the human immunodeficiency virus type one, group O (1997) (23)
- Distribution of HIV‐1 Subtypes Among HIV‐Seropositive Patients in the Interior of Côte d'Ivoire (2000) (23)
- Ensuring quality: a key consideration in scaling-up HIV-related point-of-care testing programs (2016) (22)
- Need for sustainable biobanking networks for COVID-19 and other diseases of epidemic potential (2020) (22)
- Laboratory medicine in Africa since 2008: then, now, and the future. (2018) (21)
- A quality management systems approach for CD4 testing in resource-poor settings. (2010) (21)
- Surveillance of transmitted HIV type 1 drug resistance in newly diagnosed hiv type 1-infected patients in Shandong Province, China. (2010) (21)
- A comprehensive review of the SLMTA literature part 2: Measuring success (2014) (20)
- Antiretroviral therapy in HIV-2-infected patients (2003) (20)
- Performance of six commercial enzyme immunoassays and two alternative HIV-testing algorithms for the diagnosis of HIV-1 infection in Kisumu, Western Kenya. (2011) (20)
- Trends of AIDS epidemic in Cameroon, 1986 through 1995. (1998) (20)
- A new public health order for Africa's health security. (2017) (20)
- Quantification of HIV-1 p24 by a highly improved ELISA: an alternative to HIV-1 RNA based treatment monitoring in patients from Abidjan, Côte d'Ivoire. (2006) (20)
- A pilot study of the prevalence of hepatitis C virus antibodies and hepatitis C virus RNA in southern Cameroon. (1995) (20)
- The most efficient use of resources to identify those in need of antiretroviral treatment in Africa: empirical data from Côte d'Ivoire's Drug Access Initiative (2003) (19)
- Field Validation of Limiting-Antigen Avidity Enzyme Immunoassay to Estimate HIV-1 Incidence in Cross-Sectional Survey in Swaziland. (2019) (19)
- Disease surveillance for the COVID-19 era: time for bold changes (2021) (19)
- Mapping male circumcision for HIV prevention efforts in sub-Saharan Africa (2020) (19)
- Prevalence of genotypic and phenotypic HIV‐1 drug‐resistant strains among patients who have rebound in viral load while receiving antiretroviral therapy in the UNAIDS–Drug Access Initiative in Abidjan, Côte d'Ivoire (2003) (18)
- Biological phenotypes of HIV‐1 subtypes A and B strains of diverse origins (1995) (18)
- HIV type 1 drug resistance in adults receiving highly active antiretroviral therapy in Abidjan, Côte d'Ivoire. (2009) (18)
- Presence of CRF09_cpx and complex CRF02_AG/CRF09_cpx recombinant HIV type 1 strains in Côte d'Ivoire, West Africa. (2005) (18)
- Accelerating genomics-based surveillance for COVID-19 response in Africa (2020) (18)
- African AIDS Vaccine Programme for a Coordinated and Collaborative Vaccine Development Effort on the Continent (2008) (18)
- The neutralization relationship of HIV type 1, HIV type 2, and SIVcpz is reflected in the genetic diversity that distinguishes them. (1997) (17)
- Alternative confirmatory strategy for anti-HIV antibody detection. (1992) (17)
- A novel variant of interest of SARS-CoV-2 with multiple spike mutations is identified from travel surveillance in Africa (2021) (17)
- Impact of Proficiency Testing Program for Laboratories Conducting Early Diagnosis of HIV-1 Infection in Infants in Low- to Middle-Income Countries (2013) (17)
- Strengthening national laboratory health systems in the Caribbean region (2012) (16)
- Cross‐neutralizing antibodies to HIV‐1ANT70 and HIV‐1 IIIB in sera of African and Belgian HIV‐1 -infected individuals (1994) (16)
- Quality matters in strengthening global laboratory medicine (2014) (16)
- Evaluation of Dried Blood Spots Collected on Filter Papers from Three Manufacturers Stored at Ambient Temperature for Application in HIV-1 Drug Resistance Monitoring (2014) (16)
- A comprehensive review of the SLMTA literature part 1: Content analysis and future priorities (2014) (16)
- Monitoring the Quality of HIV-1 Viral Load Testing through a Proficiency Testing Program Using Dried Tube Specimens in Resource-Limited Settings (2015) (15)
- Distribution of HIV-1 subtypes among HIV-seropositive patients in the interior of Côte d'Ivoire. (2000) (15)
- Performance of drug-resistance genotypic assays among HIV-1 infected patients with predominantly CRF02_AG strains of HIV-1 in Abidjan, Cote d'Ivoire. (2005) (15)
- A Proposed Framework for the Implementation of Early Infant Diagnosis Point-of-Care (2016) (15)
- Global health: Integrating national laboratory health systems and services in resource-limited settings (2011) (15)
- Improving laboratory efficiencies to scale-up HIV viral load testing (2017) (14)
- Molecular screening for HIV-1 group N and simian immunodeficiency virus cpz-like virus infections in Cameroon. (2000) (14)
- Country leadership and policy are critical factors for implementing laboratory accreditation in developing countries: a study on Uganda. (2010) (14)
- Positive association between beta-chemokine-producing T cells and HIV type 1 viral load in HIV-infected subjects in Abidjan, Côte d'Ivoire. (2002) (13)
- Emerging Infectious Diseases - Learning from the Past and Looking to the Future. (2021) (13)
- Improving birth and death data for African decision making. (2020) (13)
- Molecular Characterization of Ambiguous Mutations in HIV-1 Polymerase Gene: Implications for Monitoring HIV Infection Status and Drug Resistance (2013) (13)
- Implementation science: the laboratory as a command centre (2017) (13)
- Molecular Epidemiology and Transmission Dynamics of Recent and Long-Term HIV-1 Infections in Rural Western Kenya (2016) (13)
- Macrophage-tropism of HIV-1 isolates of different genetic subtypes. (1997) (13)
- Simultaneous Detection of Major Drug Resistance Mutations of HIV-1 Subtype B Viruses from Dried Blood Spot Specimens by Multiplex Allele-Specific Assay (2015) (13)
- Current HIV‐2 diagnostic strategy overestimates HIV‐2 prevalence in China (2009) (12)
- Field Evaluation of the gag-Based Heteroduplex Mobility Assay for Genetic Subtyping of Circulating Recombinant Forms of Human Immunodeficiency Virus Type 1 in Abidjan, Côte d'Ivoire (2003) (12)
- Intrapatient variability of HIV type 1 group O ANT70 during a 10-year follow-up. (1999) (12)
- COVID-19 Preventive Behaviours in Cameroon: A Six-Month Online National Survey (2021) (12)
- Quantification of RNA in HIV type 1 subtypes D and G by NucliSens and Amplicor assays in Abidjan, Ivory Coast. (1999) (12)
- Predominantly hepatitis C virus genotypes 1 and 2 are found in Cameroon. (1995) (12)
- COVID-19: unprecedented but expected (2021) (12)
- Virologic and immunologic responses to antiretroviral therapy among HIV-1 and HIV-2 dually infected patients: case reports from Abidjan, Côte d'Ivoire. (2009) (11)
- Generation of dried tube specimen for HIV-1 viral load proficiency test panels: a cost-effective alternative for external quality assessment programs. (2013) (11)
- HIV-1 group O virus infection in Abidjan, Côte d'Ivoire. (1998) (10)
- How Africa can quell the next disease outbreaks (2019) (10)
- Evaluation of a newly developed HIV antigen test (1997) (10)
- Rolling out Xpert MTB/RIF® for tuberculosis detection in HIV-positive populations: An opportunity for systems strengthening (2017) (10)
- A new matrix for scoring the functionality of national laboratory networks in Africa: introducing the LABNET scorecard (2016) (10)
- Importance of Public-Private Partnerships: Strengthening Laboratory Medicine Systems and Clinical Practice in Africa (2016) (10)
- HIV screening and confirmation: a simplified and less expensive testing algorithm. (1992) (10)
- Comparison of HIV-1 resistance profiles in plasma RNA versus PBMC DNA in heavily treated patients in Honduras, a resource-limited country. (2012) (10)
- Redesigning health systems for global heath security. (2021) (10)
- Assessing eosinophil count as a marker of immune activation among human immunodeficiency virus-infected persons in sub-Saharan Africa. (2002) (10)
- HIV-1 group O infection in Belgium. (1995) (10)
- The Global Response to the COVID-19 Pandemic (2020) (9)
- A Comprehensive Evaluation of the Proficiency Testing Program for the HIV-1 BED Incidence Assay (2011) (9)
- Author Correction: China’s response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response (2020) (8)
- Response to the Ebola virus disease outbreak in the Democratic Republic of the Congo (2018) (8)
- Field expansion of DNA polymerase chain reaction for early infant diagnosis of HIV-1: The Ethiopian experience (2013) (8)
- Public health priorities for China-Africa cooperation. (2019) (8)
- Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study (2021) (8)
- Seroprevalence and molecular epidemiology of HIV in Africa (2005) (7)
- Laboratory evaluation of the Chembio Dual Path Platform HIV-Syphilis Assay (2016) (7)
- Role of public-private partnerships in achieving UNAIDS HIV treatment targets (2019) (7)
- Lack of effect of chemokine receptor CCR2b gene polymorphism (64I) on HIV‐1 plasma RNA viral load and immune activation among HIV‐1 seropositive female workers in Abidjan, Côte d'Ivoire (2001) (7)
- Distribution of HIV-1 plasma RNA viral load and CD4 + T-cell counts among HIV-infected Africans evaluated for antiretroviral therapy. (2001) (6)
- Forests and ecocultural disequilibrium in two postcolonial novels from Cameroon and Singapore (2018) (6)
- Are post-Ebola reconstruction efforts neglecting public health laboratory systems? (2015) (6)
- Infectious virus titer, replicative and syncytium‐inducing capacity of human immunodeficiency virus type 1 (1995) (6)
- Building laboratory capacity to combat disease outbreaks in Africa (2016) (6)
- Viral, HLA and T cell elements in cross-reactive immune responses to HIV-1 subtype A, CRF01_AE and CRF02_AG vaccine sequence in Ivorian blood donors. (2008) (6)
- Preparing national tiered laboratory systems and networks to advance diagnostics in Africa and meet the continent’s health agenda: Insights into priority areas for improvement (2020) (6)
- Lessons from the elimination of poliomyelitis in Africa (2021) (6)
- C4G BLIS: Health Care Delivery via Iterative Collaborative Design in Resource-constrained Settings (2016) (6)
- Evaluation of a dried blood and plasma collection device, SampleTanker(®), for HIV type 1 drug resistance genotyping in patients receiving antiretroviral therapy. (2014) (5)
- Unexpectedly high prevalence of sexually transmitted diseases in married women attending family planning clinics in Yaounde, Cameroon (2005) (5)
- Factors Associated With Experiences of Fear, Anxiety, Depression, and Changes in Sleep Pattern During the COVID-19 Pandemic Among Adults in Nigeria: A Cross-Sectional Study (2022) (5)
- Update on the HIV epidemic in Cameroon (1993) (5)
- Improving Laboratory Efficiency in the Caribbean to Attain the World Health Organization HIV Treat All Recommendations. (2017) (5)
- Early diagnosis of HIV infection in the breastfed infant. (2012) (5)
- Improving the Quality of and Access to HIV Rapid Testing in the Caribbean Region: Program Implementation, Outcomes, and Recommendations. (2016) (4)
- Development and implementation of the Caribbean Laboratory Quality Management Systems Stepwise Improvement Process (LQMS-SIP) Towards Accreditation (2017) (4)
- Evaluation of Specimen Types for Pima CD4 Point-of-Care Testing: Advantages of Fingerstick Blood Collection into an EDTA Microtube (2018) (4)
- Global and regional governance of One Health and implications for global health security (2023) (4)
- Evaluation of different V3 peptides in an enzyme immunoassay for specific HIV type 1 group O antibody detection. (1998) (3)
- Detection of minority drug resistant mutations in Malawian HIV-1 subtype C-positive patients initiating and on first-line antiretroviral therapy (2018) (3)
- The diagnostic–clinical chasm: Work in progress? (2016) (3)
- Nursing leadership in Africa and health security (2021) (3)
- Measurement of HIV-1 CRF02_AG-specific T cell responses indicates the dominance of a p24gag epitope in blood donors in Abidjan, Cote d'Ivoire. (2005) (3)
- Building Cross-Country Networks for Laboratory Capacity and Improvement. (2018) (3)
- HIV and COVID-19: juxtaposition of two pandemics (2022) (3)
- HIV testing and human rights: the right to the right test. (2016) (3)
- HIV type 1 virological response and prevalence of HIV type 1 drug resistance among patients receiving antiretroviral therapy, Shandong, China. (2012) (3)
- Immune Activation Markers and Chemokine Receptor 5 (CCR5) Genotype in Highly Exposed But Persistently Seronegative Female Sex Workers in Abidjan, Cote d'Ivoire (1998) (2)
- Reduction of materno-fetal transmission of HIV by improved delivery techniques combined with nevirapine treatment in women attending two family planning clinics in Yaounde, Cameroon (2004) (2)
- Population-Based Serosurveys for SARS-CoV-2: Key Findings From Five African Countries: November 2020 to June 2021 (2022) (2)
- Nursing and Midwifery Knowledge, Attitudes, and Practices Towards Viral Load Testing for Managing HIV‐Infected Patients in East, Central and Southern Africa (2016) (2)
- HIV-1 group O virus infection in Abidjan Cote dIvoire [letter] (1998) (2)
- Use of pre‐ART laboratory screening to identify renal, hepatic and haematological abnormalities in Côte d'Ivoire (2020) (1)
- Impact of Proficiency Testing Program for Laboratories Conducting Early Infant (2013) (1)
- Ensuring innovation for diagnostics for bacterial infection to combat antimicrobial resistance (2020) (1)
- Update on the HIV epidemic in Cameroon [letter] (1993) (1)
- China’s response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response (2020) (1)
- Leveraging gains from African Center for Integrated Laboratory Training to combat HIV epidemic in sub-Saharan Africa (2021) (1)
- Hepatitis C virus antibody, viraemia and genotypes in individuals infected with HIV-1 in Cameroon. (1994) (1)
- The performance of using dried blood spot specimens for HIV-1 viral load testing: A systematic review and meta-analysis (2022) (1)
- Black Caps and Red Feathers (2010) (1)
- Letters to Marion (and the Coming Generations) (2009) (1)
- Infant HIV diagnosis and turn-around time for testing in Malawi, 2015 (2020) (1)
- Leveraging HIV Program and Civil Society to Accelerate COVID-19 Vaccine Uptake, Zambia (2022) (1)
- Adherence to COVID-19 preventive measures in Sub-Saharan Africa during the 1st year of the pandemic: Pooled analysis of the International Citizen Project on COVID-19 (ICPCovid) surveys (2022) (1)
- Access to HIV viral load testing and antiretroviral therapy switch practices: a multi-country prospective cohort study in sub-Saharan Africa. (2020) (1)
- Legal and policy barriers for an effective HIV/AIDS response (2023) (0)
- Let Africa into the market for COVID-19 diagnostics (2020) (0)
- in Blood Donors in Abidjan (2005) (0)
- Launching the Kofi Annan Global Health Leadership Programme (2020) (0)
- A Comprehensive Evaluation of the Proficiency Testing Program for the HIV-1 BED Incidence Assay (cid:1) (2011) (0)
- LSHTM Online (2020) (0)
- Onsite healthcare worker acceptability and performance of the point-of-care Pima CD4 assay in Dar es Salaam, Tanzania (2019) (0)
- How Africa can quell the next disease outbreaks (2019) (0)
- Global Public Health: An International Journal for Research, Policy and (2012) (0)
- Corrigendum: Assuring the quality of diagnostic testing: the future is now (2017) (0)
- Religious Consciousness in Joseph Conrad’s Heart of Darkness and James Joyce’s A Portrait of the Artist as a Young Man (2020) (0)
- Infectious Diseases Threat and Africa’s Health Security (2017) (0)
- [Preliminary survey of human immunodeficiency virus 1, group O in Burundi]. (1995) (0)
- Allele-Specific Assay Subtype C by Use of a Multiplex Reverse Transcriptase Genes for HIV-1 Resistance Mutations in the Protease and Simultaneous Detection of Major Drug (2013) (0)
- Author Correction: China’s response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response (2020) (0)
- Vital Signs: Progress Toward Eliminating HIV as a Global Public Health Threat Through Scale-Up of Antiretroviral Therapy and Health System Strengthening Supported by the U.S. President’s Emergency Plan for AIDS Relief — Worldwide, 2004–2022 (2023) (0)
- COVID-19 in Africa: the spread and response (2020) (0)
- The puzzle of the COVID-19 pandemic in Africa: more data are needed to understand the determinants of the COVID-19 pandemic across Africa (2021) (0)
- Long-term immunological responses to treatment among HIV-2 patients in Côte d’Ivoire (2020) (0)
- Laboratory equipment maintenance: A critical bottleneck for strengthening health systems in sub-Saharan Africa? (2011) (0)
- Audio Interview: Infectious Disease in Africa. (2022) (0)
- The Naked Muse: Echoes from a Writer’s Soul (2008) (0)
This paper list is powered by the following services:
Other Resources About John Nkengasong
What Schools Are Affiliated With John Nkengasong?
John Nkengasong is affiliated with the following schools:
